Evident intravascular ultrasound system receives FDA clearance; clinical benefits of AI remain to be validated
The peripheral vascular imaging platform combines real-time processing with voice control and has cleared a regulatory hurdle for market entry. However, public documents provide no clinical performance testing, and planned AI capabilities must be considered separately from this clearance.